Potassium responses to sodium zirconium cyclosilicate in hyperkalemic hemodialysis patients: post-hoc analysis of DIALIZE.


Journal

BMC nephrology
ISSN: 1471-2369
Titre abrégé: BMC Nephrol
Pays: England
ID NLM: 100967793

Informations de publication

Date de publication:
08 02 2022
Historique:
received: 23 03 2021
accepted: 14 09 2021
entrez: 9 2 2022
pubmed: 10 2 2022
medline: 11 3 2022
Statut: epublish

Résumé

Sodium zirconium cyclosilicate (SZC) is an effective and well-tolerated treatment for hyperkalemia in maintenance hemodialysis patients. In post-hoc analyses of the phase 3b DIALIZE study, we examined the spectrum of potassium responses to SZC. Post-hoc analyses with SZC and placebo included: the number of long interdialytic interval (LIDI) visits during the 4-week evaluation period where patients attained pre-dialysis serum potassium (sK A greater proportion of patients achieved the ranges of pre-dialysis sK These analyses expand our knowledge of the spectrum of potassium responses with SZC in hyperkalemic hemodialysis patients. NCT03303521 .

Sections du résumé

BACKGROUND
Sodium zirconium cyclosilicate (SZC) is an effective and well-tolerated treatment for hyperkalemia in maintenance hemodialysis patients. In post-hoc analyses of the phase 3b DIALIZE study, we examined the spectrum of potassium responses to SZC.
METHODS
Post-hoc analyses with SZC and placebo included: the number of long interdialytic interval (LIDI) visits during the 4-week evaluation period where patients attained pre-dialysis serum potassium (sK
RESULTS
A greater proportion of patients achieved the ranges of pre-dialysis sK
CONCLUSIONS
These analyses expand our knowledge of the spectrum of potassium responses with SZC in hyperkalemic hemodialysis patients.
TRIAL REGISTRATION
NCT03303521 .

Identifiants

pubmed: 35135481
doi: 10.1186/s12882-021-02569-7
pii: 10.1186/s12882-021-02569-7
pmc: PMC8826669
doi:

Substances chimiques

Dialysis Solutions 0
Ion Exchange Resins 0
Silicates 0
sodium zirconium cyclosilicate D652ZWF066
Potassium RWP5GA015D

Banques de données

ClinicalTrials.gov
['NCT03303521']

Types de publication

Clinical Trial, Phase III Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

59

Informations de copyright

© 2022. The Author(s).

Références

Clin J Am Soc Nephrol. 2007 Sep;2(5):999-1007
pubmed: 17702709
Nephrol Dial Transplant. 2009 Aug;24(8):2529-36
pubmed: 19293137
Kidney Int. 1996 Aug;50(2):609-17
pubmed: 8840293
Curr Opin Nephrol Hypertens. 2015 Nov;24(6):557-62
pubmed: 26406807
Clin J Am Soc Nephrol. 2019 Jun 7;14(6):798-809
pubmed: 31110051
Eur J Heart Fail. 2015 Oct;17(10):1050-6
pubmed: 26011677
BMC Nephrol. 2019 Oct 17;20(1):379
pubmed: 31623578
Am J Kidney Dis. 2017 Jul;70(1):21-29
pubmed: 28111027
N Engl J Med. 2015 Jan 15;372(3):222-31
pubmed: 25415807
Am J Nephrol. 2019;50(6):473-480
pubmed: 31658466
N Engl J Med. 2011 Sep 22;365(12):1099-107
pubmed: 21992122
Kidney Int. 2015 Aug;88(2):404-11
pubmed: 25651363
PLoS One. 2014 Dec 22;9(12):e114686
pubmed: 25531770
J Am Soc Nephrol. 2017 Dec;28(12):3441-3451
pubmed: 28993507
Am J Nephrol. 2018;47(6):415-423
pubmed: 29879714
Kidney Int. 2020 Jan;97(1):42-61
pubmed: 31706619
Clin J Am Soc Nephrol. 2012 May;7(5):765-74
pubmed: 22403271
Nephrol Dial Transplant. 2008 Apr;23(4):1415-21
pubmed: 18065796
Am J Kidney Dis. 2015 Jul;66(1):125-32
pubmed: 25828570
Kidney Int. 2001 Jul;60(1):350-7
pubmed: 11422771
Nephrol Dial Transplant. 2018 Jul 1;33(7):1207-1214
pubmed: 28992343
Am J Kidney Dis. 1989 Feb;13(2):137-43
pubmed: 2916568
Am J Nephrol. 2016;44(3):179-86
pubmed: 27592170
J Nephrol. 2010 Jan-Feb;23(1):33-40
pubmed: 20091484
Clin Kidney J. 2015 Oct;8(5):580-9
pubmed: 26413285
J Am Soc Nephrol. 2019 Sep;30(9):1723-1733
pubmed: 31201218
Am J Kidney Dis. 2017 Feb;69(2):266-277
pubmed: 27866964
Kidney Int. 2011 Jan;79(2):218-27
pubmed: 20811332
Nephrol Dial Transplant. 2001 Jan;16(1):78-84
pubmed: 11208997
Hemodial Int. 2015 Jan;19(1):23-32
pubmed: 25091596
JAMA. 2014 Dec 3;312(21):2223-33
pubmed: 25402495

Auteurs

Steven Fishbane (S)

Department of Medicine, Zucker School of Medicine at Hofstra/Northwell, 100 Community Dr, Great Neck, NY, 11021, USA. Sfishbane@northwell.edu.

Martin Ford (M)

Department of Renal Medicine, King's College Hospital NHS Trust, London, UK.
Faculty of Life Sciences and Medicine, King's College, London, UK.

Masafumi Fukagawa (M)

Division of Nephrology, Endocrinology and Metabolism, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Japan.

Kieran McCafferty (K)

Department of Nephrology, Bart's Health NHS Trust, London, UK.

Anjay Rastogi (A)

UCLA CORE Kidney Program, University of California Los Angeles, Los Angeles, CA, USA.

Bruce Spinowitz (B)

Department of Medicine, New York-Presbyterian Queens, Queens, NY, USA.

Konstantin Staroselskiy (K)

Department #2, B. Braun Avitum Russland Clinics, St Petersburg, Russia.

Konstantin Vishnevskiy (K)

Propedeutics of Internal Diseases Chair, First Pavlov State Medical University of St Petersburg, St Petersburg, Russia.

Vera Lisovskaja (V)

Biometrics and Information, AstraZeneca BioPharmaceuticals R&D Gothenburg, Mölndal, Sweden.

Ayman Al-Shurbaji (A)

Global Medicines Development, AstraZeneca BioPharmaceuticals R&D Gothenburg, Mölndal, Sweden.

Nicolas Guzman (N)

Global Medicines Development, AstraZeneca BioPharmaceuticals R&D, Gaithersburg, MD, USA.

Sunil Bhandari (S)

Department of Renal and Transplant Medicine, Hull University Teaching Hospitals NHS Trust, Hull, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH